Arbutus Biopharma Corp is a biotechnology company focused on developing innovative therapies for viral infections, particularly those caused by the hepatitis B virus (HBV)

The company is engaged in the discovery and development of a range of novel compounds aimed at addressing unmet medical needs in the treatment of chronic viral diseases. Arbutus employs a diverse approach to its research and development efforts, including the utilization of RNA interference technology and other mechanisms to advance its therapeutic candidates. Through its commitment to scientific excellence, Arbutus aims to provide effective treatment options that can significantly improve the lives of patients affected by viral infections.